scholarly article | Q13442814 |
P50 | author | Pratap Parida | Q42722493 |
Dipak Paul | Q99619185 | ||
Debamitra Chakravorty | Q99619186 | ||
P2860 | cites work | Cytoscape: a software environment for integrated models of biomolecular interaction networks | Q24515682 |
Electrostatics of nanosystems: application to microtubules and the ribosome | Q24555224 | ||
Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs | Q27641252 | ||
The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor | Q27642450 | ||
Severe acute respiratory syndrome-associated coronavirus nucleocapsid protein interacts with Smad3 and modulates transforming growth factor-beta signaling | Q28259664 | ||
ACPYPE - AnteChamber PYthon Parser interfacE | Q28465578 | ||
REVIGO summarizes and visualizes long lists of gene ontology terms | Q29614817 | ||
Essential dynamics of proteins | Q29616843 | ||
Protein dynamics simulations from nanoseconds to microseconds | Q33632659 | ||
Baicalin, a metabolite of baicalein with antiviral activity against dengue virus | Q33807926 | ||
Structure of SARS coronavirus spike receptor-binding domain complexed with receptor | Q34451350 | ||
VirusMINT: a viral protein interaction database | Q34599520 | ||
Role of advanced glycation end products in cardiovascular disease. | Q35929112 | ||
Enrichr: a comprehensive gene set enrichment analysis web server 2016 update | Q36007700 | ||
Interaction of viral proteins with metal ions: role in maintaining the structure and functions of viruses | Q36024395 | ||
Complex interactions between phytochemicals. The multi-target therapeutic concept of phytotherapy | Q37782112 | ||
Recent advances in protein-ligand interactions: molecular dynamics simulations and binding free energy. | Q38153763 | ||
Inhibition of human coronavirus 229E infection in human epithelial lung cells (L132) by chloroquine: involvement of p38 MAPK and ERK. | Q40041391 | ||
g_mmpbsa--a GROMACS tool for high-throughput MM-PBSA calculations. | Q42217335 | ||
SwissTargetPrediction: a web server for target prediction of bioactive small molecules | Q42724602 | ||
Bio3d: an R package for the comparative analysis of protein structures. | Q46122078 | ||
Fluctuation and Cross-correlation Analysis of Protein Motions Observed in Nanosecond Molecular Dynamics Simulations | Q57204729 | ||
Antiviral Efficacy of Flavonoids against Enterovirus 71 Infection in Vitro and in Newborn Mice | Q66679210 | ||
Baricitinib as potential treatment for 2019-nCoV acute respiratory disease | Q84363411 | ||
A pneumonia outbreak associated with a new coronavirus of probable bat origin | Q84367633 | ||
A new coronavirus associated with human respiratory disease in China | Q84956787 | ||
A Novel Coronavirus from Patients with Pneumonia in China, 2019 | Q86729469 | ||
Structure analysis of the receptor binding of 2019-nCoV | Q87461487 | ||
Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody | Q87461535 | ||
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors | Q88219766 | ||
Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission | Q89490397 | ||
Clinical Characteristics of Coronavirus Disease 2019 in China | Q89934806 | ||
Structure of mouse coronavirus spike protein complexed with receptor reveals mechanism for viral entry | Q90160073 | ||
The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase | Q90292823 | ||
Amygdalin as multi-target anticancer drug against targets of cell division cycle: double docking and molecular dynamics simulation | Q90341972 | ||
Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach | Q90830654 | ||
Prediction of Deleterious Non-synonymous SNPs of Human STK11 Gene by Combining Algorithms, Molecular Docking, and Molecular Dynamics Simulation | Q91235459 | ||
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2 | Q91807337 | ||
Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants | Q91974643 | ||
Discovery of Potential Multi-Target-Directed Ligands by Targeting Host-specific SARS-CoV-2 Structurally Conserved Main Protease$ | Q93204080 | ||
Putative Inhibitors of SARS-CoV-2 Main Protease from A Library of Marine Natural Products: A Virtual Screening and Molecular Modeling Study | Q93263973 | ||
Candidate drugs against SARS-CoV-2 and COVID-19 | Q94491475 | ||
Potential Inhibitors of Coronavirus 3-Chymotrypsin-Like Protease (3CLpro): An in silico screening of Alkaloids and Terpenoids from African medicinal plants | Q94524420 | ||
Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n=4532) | Q94589790 | ||
In Silico Exploration of Molecular Mechanism of Clinically Oriented Drugs for Possibly Inhibiting SARS-CoV-2's Main Protease | Q94677438 | ||
Withanone and Caffeic Acid Phenethyl Ester are Predicted to Interact with Main Protease (Mpro) of SARS-CoV-2 and Inhibit its Activity | Q95285160 | ||
p38 MAPK inhibition: A promising therapeutic approach for COVID-19 | Q95295019 | ||
In-silico investigation of phytochemicals from Asparagus racemosus as plausible antiviral agent in COVID-19 | Q96647558 | ||
P4510 | describes a project that uses | Cytoscape | Q3699942 |
RStudio | Q4798119 | ||
P921 | main subject | medicinal plant | Q188840 |
phytochemistry | Q640068 | ||
SARS-CoV-2 | Q82069695 | ||
P577 | publication date | 2020-09-24 | |
P1433 | published in | Phytotherapy Research | Q7189844 |
P1476 | title | The natural way forward: Molecular dynamics simulation analysis of phytochemicals from Indian medicinal plants as potential inhibitors of SARS-CoV-2 targets |
Search more.